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Prostaglandin E2 (PGE2) is a lipid mediator released from the phospholipid membranes that mediates
important physiological functions in the nervous system via activation of four EP receptors (EP1-4). There
is growing evidence for the important role of the PGE2/EP4 signaling in the nervous system. Previous
studies in our lab show that the expression of the EP4 receptor is signiﬁcantly higher during the neu-
rogenesis period in the mouse. We also showed that in mouse neuroblastoma cells, the PGE2/EP4 re-
ceptor signaling pathway plays a role in regulation of intracellular calcium via a phosphoinositide
3-kinase (PI3K)-dependent mechanism. Recent research indicates that the functional importance of the
EP4 receptor depends on its subcellular localization. PGE2-induced EP4 externalization to the plasma
membrane of primary sensory neurons has been shown to play a role in the pain pathway. In the present
study, we detected a novel PGE2–dependent subcellular trafﬁcking of the EP4 receptor in neuroecto-
dermal (NE-4C) stem cells and differentiated NE-4C neuronal cells. We show that PGE2 induces EP4
externalization from the Golgi apparatus to the plasma membrane in NE-4C stem cells. We also show
that the EP4 receptors translocate to growth cones of differentiating NE-4C neuronal cells and that a
higher level of PGE2 enhances its growth cone localization. These results demonstrate that the EP4 re-
ceptor relocation to the plasma membrane and growth cones in NE-4C cells is PGE2 dependent. Thus, the
functional role of the PGE2/EP4 pathway in the developing nervous system may depend on the sub-
cellular localization of the EP4 receptor.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prostaglandin E2 (PGE2) is a bioactive lipid derived from plas-
ma membrane phospholipids, through enzymatic metabolism of
arachidonic acid by cyclooxygenases -1 and -2 (COX -1,-2) and
prostaglandin synthase [1]. PGE2 mediates biosynthetic pathways
that regulate biological functions such as sleep, fever, inﬂamma-
tion, and pain [2]. PGE2 also plays a critical role in the proper
development of the nervous system. It induces differentiation of
neuronal cells [3] and plays a regulatory role in membrane excit-
ability and synaptic transmission in neurons [4]. PGE2 can also
increase dendritic length and alter neuronal ﬁring activity in the
brain [5].
PGE2 exerts it physiological function through its four cell sur-
face G protein-coupled receptors (GPCRs) designated EP (E-Pros-
tanoid) 1-4, with different afﬁnities [1,6,7]. Activation of EP1B.V. This is an open access article u
rsity, 4700 Keele Street, Tor-receptor is associated with an increase of intracellular calcium
[Ca2þ]i, mediated by phospholipase C and inositol 1,4,5-tripho-
sphate (IP3) [7,8]. EP2 and EP4 are coupled to the stimulatory Gs
protein and cause an increase in cAMP through activation of
adenylate cyclase [9], which in turn activates protein kinase A
(PKA) and mediates phosphorylation of cAMP response element
binding the protein (CREB) transcription factor [10]. Activation of a
speciﬁc EP3 isoform, can both decrease and increase cyclic AMP
(cAMP) and IP3. It is also shown that the EP4 receptor signaling
can operate via Gi proteins- phosphatidylinositol-4,5-bispho-
sphate 3-kinase (PI3K) pathways [11,12].
Interest in the PGE2/EP4 pathway is increasing given its diverse
capability of regulating central nervous system activity [13]. EP4
has a protective function by reducing cerebral injury and im-
proving functional outcome after stroke [14], and in suppressing
brain inﬂammation [15]. The EP4 receptor has been suggested to
contribute to PGE2-induced changes in body temperature [16].
Furthermore, EP4 activation can decrease the level of amyloid-beta
in the brain and improve behavioral performance in a murine
model of Alzheimer's disease [17]. The EP4 receptor along with
EP3C (EP3γ) mediates PGE2-induced sensitization of sensorynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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root ganglion neurons may also contribute to the transition from
acute to chronic pain by facilitating EP4 receptor synthesis and
anterograde axonal trafﬁcking [19]. We have previously found that
the PGE2/EP4 pathway plays an inhibitory role in regulating the
intracellular calcium homeostasis in mouse neuroblastoma (Neu-
ro-2a) cells via PI3K mechanism [20]. Expression of the EP4 re-
ceptor is higher during early neurogenesis as compared to later
embryonic stages in mouse embryos suggesting its importance in
the developing nervous system [21].
Recent research shows that the subcellular trafﬁcking of the
EP4 receptor may have functional implications. It has been shown
that PGE2-induced EP4 externalization to the plasma membrane in
dorsal root ganglion neurons is important for the inﬂammatory
pain response [22]. The goal of this study was to determine
whether PGE2 can also induce EP4 receptor trafﬁcking in neu-
roectodermal (NE-4C) stem cells used as an experimental model
system for early neuronal development. We show that PGE2 causes
translocation of the EP4 receptor from its normal location in the
Golgi apparatus [23] to the plasma membrane in undifferentiated
NE-4C stem cells. This was conﬁrmed with a speciﬁc EP4 receptor
agonist. We also show for the ﬁrst time that PGE2 can enhance
trafﬁcking of the EP4 receptor to growth cones of differentiated
neuronal NE-4C cells. This study shows that PGE2 can inﬂuence the
subcellular localization of the EP4 receptor in neuronal stem cells
and differentiated neuronal cells.2. Methods
2.1. Cell cultures
Mouse neuroectodermal (NE-4C) stem cell line was obtained from
American Tissue Culture Collection (ATCC) and grown in Minimum
Essential Medium (MEM) supplemented with 10% fetal bovine serum,
2 mM glutamine, 1X penicillin-streptomycin mixture (Invitrogen).
Cells were maintained in an incubator containing 5% CO2 at 95%
humidity at 37 °C. Cells were plated on 0.01% poly-L-lysine (Sigma)
coated 100 mm culture plate (BD Falcon) and subcultured at a 1:10
ratio. Supplemented MEM was changed every 2 days. NE-4C cells
were seeded onto culture plates containing poly-L-lysine and in-
cubated overnight at 37 °C before treatment.
2.2. Differentiation of NE-4C stem cells into neurons
Differentiation of NE-4C cells was induced on day 0 using
Neurobasal media (NBM; supplemented with L-glutamate, 1 Pen
Strep, and 1 B-27; Invitrogen) in poly-L-lysine (Sigma, MW
70,000–150,000 kDa) pre-coated 100 mm culture plates. By day 6,
neurospheres (clusters of neural stem cells) were dissociated,
seeded onto 35 mm culture plates containing poly-L-lysine coated
coverslips and grown until day 12. Supplemented differentiating
media was replaced every 2 days. Pou Class 5 homeobox 1 (Pou5f1)
and Mouse BIII tubulin (Tubb3) were used on day 12 as stem cell
and late neuronal cell markers to conﬁrm differentiation using
PCR. PCR primers are as follows: Pou5f1 forward 5′-
CTGGCTAAGCTTCCAAGGGC-3′ and reverse 5′-CCAGGGTCTCC-
GATTTGCAT-3′ Tubb3 5′-AGCAGCTACTTCGTGGAGTG-3′ and reverse
5′-GGGCTTCCGATTCCTCGTCA-3′. As compared to day 0, which
showed presence of the Pou5f1 marker, we conﬁrmed that on day
12 only the Tubb3 marker was detected (data not shown).2.3. Cell culture treatments
To explore the time course of PGE2-induced EP4 externaliza-
tion, we subjected NE-4C cells to 10 mM PGE2 (Sigma) for 1, 3 and
24 h (hours). The abundance of EP4 at the plasma membrane ap-
peared after 3 h, thus we selected the 3 h time for the following
experiments. We also subjected NE-4C cells to 1 and 10 mM con-
centration of PGE2 for 3 h (no effect seen by 1 mM). Controls con-
tained a corresponding concentration of the PGE2 organic solvent
DMSO (dimethyl sulfoxide).
PGE2-dependent EP4 externalization was conﬁrmed using EP4
agonist (CAY10580; Cayman Chemicals; 10, 50, 100 mM) for 3 h,
with representative ﬁgures presented. CAY10580 is commonly
used because it is highly speciﬁc (60–85 times) to the EP4 receptor
compared to the other EP receptors [24]. Speciﬁcity of this ex-
ternalization was conﬁrmed through use of EP4 antagonist
(AH23848; Cayman Chemicals; 100 mM) alone. To ensure sufﬁcient
EP4 receptor blocking prior to co-treatment with the agonist or
PGE2, a pre-treatment (1 h) was applied followed by co-treatment
(3 h) with CAY10580 (100 mM) and PGE2 (10 mM). PGE2-induced
EP4 translocation was also performed in NE-4C cells differentiated
into neurons after 12 days. PGE2 (1 and 10 mM) was applied to
differentiated cells for 3 and 24 h, and compared to the untreated
control group (DMSO vehicle). Treatment concentrations of PGE2,
CAY10580, and AH23848 tested in this study are within a con-
centration range widely used in various neural cell types
[21,22,25–27].
2.4. Immunocytochemistry
The cells were ﬁxed with 4% paraformaldehyde (PFA) in phos-
phate buffered saline (4.3 mM Na2HPO4, 137 mM NaCl, 2.7 mM
KCl, 1.4 mM KH2PO4) for 20 min at 4 °C and rinsed twice with PBS.
Cells were then permeabilized with 0.3% Triton X-100 and 2%
Normal Goat Serum (NGS) in PBS for 20 min, followed by in-
cubation of primary antibodies in TBS-T (TBS-Tween 20, 0.05%) and
2% NGS.
Cellular localization of the EP4 receptor in NE-4C cells was
determined as we previously described [23]. In brief, incubation
with anti-rabbit EP4 primary antibody (1:60; Santa Cruz Bio-
technologies) along with monoclonal anti-mouse PMCA1 plasma
membrane marker (1:500; Abcam), at room temperature for 2 h.
Following primary antibody incubation, cells were washed three
times with PBS for 5 min and incubated with secondary antibodies
in TBS-T (TBS-Tween 20, 0.05%) and 2% NGS for 1 h at room tem-
perature in the dark.
Secondary antibodies used were anti-rabbit ﬂuorescein iso-
thiocyanate (FITC) (1:100; Jackson ImmunoResearch Laboratories)
and anti-mouse Texas Red (1:200; Jackson ImmunoResearch La-
boratories). Cells were then washed three times with PBS for
5 min, followed by a 10 min incubation of 4′,6-diamidino-2-
phenylindole (DAPI) (1:10,000; Molecular Probes) at room tem-
perature in the dark. Cells were washed three times with PBS for
5 min and coverslips were mounted on glass microscope slides
with anti-fade mounting media (Invitrogen). The staining was vi-
sualized and captured using an Olympus Fluoview 300 Confocal
Laser Scanning Microscope. Secondary antibodies were used
without primary antibodies to serve as a control for speciﬁcity (not
shown). Control staining completed with the absence of respective
primary antibody revealed that each antibody was speciﬁc to the
target (not shown). We also previously tested the speciﬁcity of the
same EP4 primary antibody via immunocytochemistry and wes-
tern blot analysis [21,23].
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NIS Elements software (Nikon) was used to measure the signal
intensity of EP4 receptor at the plasma membrane in un-
differentiated NE-4C stem cells. A line of 3pt width was drawn
around the plasma membrane (perimeter of the cell) using the
PMCA1 marker to deﬁne the perimeter. Once the plasma mem-
brane was outlined, the region of interest (ROI) was overlaid on
the EP4 image in the same location, and then the mean signal
intensity was measured. The mean signal intensity accounts for
the area of the ROI (line; lengthwidth) overlaying the plasma
membrane. The EP4 signal intensity is presented as a ratio in
comparison to the control. Growth cone signal intensity of ﬂuor-
escence was measured using the same technique with ImageJ
software [28]. EP4 receptor intensity in the plasma membrane and
at the growth cone was taken as a mean for each treatment and
compared to the mean of the control (DMSO, vehicle), and pre-
sented as a ratio value in comparison to the control. BackgroundFig. 1. PGE2–induced EP4 localization at the plasma membrane in undifferentiated NE-4C
(Anti-EP4; top panel); plasma membrane marker (anti-PMCA1; middle panel); merged im
no PGE2 control and at the plasma membrane with 10 μM PGE2. The plasma membrane l
was no effect with antagonist alone (100 μM AH). The scale bar represents 10 μm. B. Quan
depicted as a ratio value in comparison to no PGE2 group (set at 1.0); 10 μM PGE2 signiﬁcasignals were subtracted from the signal intensity measurements
for each cell and growth cone. Treatment groups were compared
to the untreated group and was considered statistically signiﬁcant
at po0.05 by ANOVA and/or a student's t-test.3. Results
3.1. PGE2 induces EP4 externalization to the plasma membrane in
undifferentiated NE-4C stem cells
We previously established that undifferentiated neuroectodermal
NE-4C stem cells express all EP1-4 receptors and that the EP4 re-
ceptor is normally localized in the Golgi apparatus [23]. To determine
if PGE2 can induce EP4 cell surface externalization in NE-4C cells,
undifferentiated NE-4C cells were treated with 1 and 10 mM of PGE2.
Similar to untreated NE-4C cells, the 1 mM and 10 mM PGE2-treated
cells show EP4 present in the Golgi apparatus (only 10 mM PGE2 isstem cells. A. Immunocytochemistry visualization of EP4 receptor. The EP4 receptor
ages (the nucleus marker DAPI; lower panel). EP4 localizes to the Golgi apparatus in
ocalization was blocked by the EP4 antagonist (10 μM PGE2þ100 μM AH), and there
tiﬁcation of immunoﬂuorescent EP4 receptor localization at the plasma membrane
ntly increased the EP4 at the plasma membrane (po0.05). PGE2¼prostaglandin E2.
Fig. 2. Agonist–induced EP4 localization at the plasma membrane in undifferentiated NE-4C stem cells. A. Immunocytochemistry visualization of EP4 receptor. The EP4
receptor (Anti-EP4; top panel); plasma membrane marker (anti-PMCA1; middle panel); merged images (the nucleus marker DAPI; lower panel). EP4 receptor localization at
the plasma membrane with EP4 agonist (100 μM CAY) was blocked with EP4 antagonist (100 μM CAYþ100 μM AH). The scale bar represents 10 μm. B. Quantiﬁcation of
immunoﬂuorescent EP4 receptor localization at the plasma membrane depicted as a ratio value in comparison to no PGE2 group (set at 1.0); 100 μM CAY signiﬁcantly
increased the EP4 at the plasma membrane (po0.05).
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localized in the peripheral regionwith the PMCA1 (plasmamembrane
Ca2þ-ATPase) marker, suggesting dose-dependent PGE2-induced EP4translocation toward the plasma membrane (Fig. 1(A)). The EP4
plasma membrane externalization in NE-4C cells became apparent
after 3 h exposure to 10 mM PGE2.
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membrane was inhibited by a selective EP4 antagonist, AH23848.
AH23848 alone had no effect on the EP4 trafﬁcking (Fig. 1(A)). This
indicates that the trafﬁcking likely occurred through the EP4 re-
ceptor. We veriﬁed the increased abundance of EP4 receptor at the
plasma membrane through immunoﬂuorescence quantiﬁcation
(Fig. 1(B)). Immunoﬂuorescence intensity ratios in cells treated
with PGE2 and with the addition of the EP4 antagonist (AH23848)
were calculated by comparing the EP4 staining intensity in the cell
membrane of each corresponding treatment condition to the
control condition without PGE2. These results show a novel
PGE2-dependent subcellular translocation of the EP4 receptor in
NE-4C stem cells.
3.2. EP4 receptor agonist induces EP4 externalization to the plasma
membrane in undifferentiated NE-4C stem cells
The PGE2-induced EP4 externalization in undifferentiated NE-
4C cells was conﬁrmed with a selective EP4 agonist (CAY10580).
We used 10, 50 and 100 mM treatment with CAY10580 for 3 h [22].
Similar to PGE2, the CAY10580 also induced EP4 externalization to
the plasma membrane. All CAY10580 concentrations tested show
the Golgi expression whereas the 100 mM signiﬁcantly increased
the EP4 externalization to the plasma membrane (Fig. 2(A)).
AH23848 blocked CAY10580-induced EP4 externalization (Fig. 2
(A)), which was conﬁrmed through immunoﬂuorescence quanti-
ﬁcation via intensity ratios (Fig. 2(B)). Immunoﬂuorescence in-
tensity ratios of EP4 staining were calculated by comparing the
treatment conditions to the control without PGE2. Overall, these
results suggest that the EP4 receptor subcellular re-location from
the Golgi apparatus to the plasma membrane is regulated though
the EP4 signaling pathway.
3.3. PGE2 dependent EP4 receptor localization in differentiated NE-
4C neuronal cells
Given the increasingly important role of EP4 in the developing
nervous system, we also assessed the localization of the EP4 re-
ceptor in differentiated NE-4C neuronal cells. Similar to NE-4C
stem cells, we only observed typical Golgi localization in differ-
entiated NE-4C cells (Fig. 3) after exposure to PGE2 with no ap-
parent trafﬁcking to the plasma membrane. Interestingly, we show
for the ﬁrst time that the endogenous EP4 receptor was also pre-
sent in the growth cones of untreated differentiated NE-4C cells
(Fig. 4(A)). Moreover, exposure to 1 and 10 mM concentrations of
PGE2 resulted in signiﬁcantly increased localization of EP4 in the
growth cones after 3 h that remained unchanged for the durationFig. 3. EP4 receptor localization in differentiated NE-4C cells. The EP4 receptor (Anti-EP4
(the nucleus marker DAPI; right panel). EP4 receptor is localized in the Golgi apparatusof 24 h (Fig. 4(A) and (B)). There was no signiﬁcant difference
between the 1 and 10 mM PGE2 treatments at 3 or 24 h.4. Discussion
The results of this study show that 10 mM PGE2 induces EP4
externalization from its previously characterized localization in
the Golgi apparatus [23] to the plasma membrane in un-
differentiated NE-4C stem cells. 1 mM PGE2 did not have a sig-
niﬁcant effect on undifferentiated NE-4C stem cells, indicating that
EP4-translocation may be PGE2 concentration-dependent. Inter-
estingly, we also found that in differentiated NE-4C neuronal cells,
1 or 10 mM PGE2 enhanced EP4 trafﬁcking to the growth cones. The
observed subcellular translocation of the EP4 receptor from its
normal location in the Golgi apparatus to the plasma membrane
and growth cones indicates that it may play an important role in
early function of neuronal cells.
The functional importance of PGE2-induced subcellular locali-
zation of the EP4 receptor in the developing nervous system is still
largely unknown. Whether EP4 signaling in various subcellular
compartments of NE-4C cells is regulated by Gs and/or Gi proteins
still needs further investigation. PGE2-mediated EP4 activation of
either Gs or Gi may result in increased or decreased cAMP-PKA
signaling respectively [29]. EP4 activity may also stimulate cAMP-
independent signaling through PI3K activation [29]. However,
there is growing evidence for the functional importance of the
PGE2/EP4 signaling in the developing nervous system. The
PGE2/EP4 pathway has been suggested to play a role in the tran-
sition from acute to chronic pain in nociceptive dorsal root gang-
lion neurons [19]. St. Jacques and Ma found that PGE2-prolonged
sensitization of neurons facilitated the synthesis and anterograde
axonal trafﬁcking of EP4 receptors [19]. Our previous study shows
that EP4 is involved in PGE2-dependent regulation of intracellular
calcium level through a novel PI3K inhibitory mechanism and it
also reduces neurite lengths in differentiated Neuro-2a cells [20].
This is interesting because calcium ions are key mediators to
multiple cellular processes in early neuronal development. For
example, in neuronal growth cones calcium contributes to axonal
growth and guidance, which must be strictly regulated during
neuronal development [30–32]. Interestingly, we also showed that
the level of the EP4 receptor is higher in the mouse embryo
(embryonic stage 7, 11 and 15) as compared to the later stage E17
[21], indicating its important role in early development.
PGE2-EP4 activation has been found to attenuate the activation of
microglia and to prevent lipid peroxidation and pro-inﬂammatory gene
expression in a murine model of lipopolysaccharide (LPS)-induced; left panel); plasma membrane marker (anti-PMCA1; middle panel); merge images
. Scale bar represents 10 μm. PGE2¼prostaglandin E2.
Fig. 4. EP4 Receptor localization in the growth cones of differentiated NE-4C cells. A. The EP4 receptor (Anti-EP4) merged image with plasma membrane marker (Anti-
PMCA1). 1 μM and 10 μM PGE2 treatment for 3 h (top row), 24 h (bottom row). Scale bar represents 5 μm. B. Quantiﬁcation of immunoﬂuorescent EP4 receptor localization in
the growth cones using only the green ﬂuorescent channel depicted as a ratio value in comparison to no PGE2 group (set at 1.0); Both 1 μM and 10 μM PGE2 signiﬁcantly
increased the EP4 in the growth cones after 3 and 24 h (po0.05). PGE2¼prostaglandin E2.
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protective function in reducing injury and improving functional re-
covery after stroke via dual and independent cell-speciﬁc mechanisms
of neuroprotection and enhanced vascular perfusion [14]. In contrast,
genetic and pharmacologic inhibition of EP4 receptor, via EP4 deﬁ-
ciency or antagonist respectively, in a murine mouse model of Alz-
heimer's disease decreased amyloid-β levels in the brain and improved
the behavioral performance of the animals [17]. EP4 receptors are the
most widely expressed PGE2 receptors in the body [13], and the various
biological effects observed due to PGE2 signaling via EP4 may be
mediated by the externalization of EP4 to the plasma membrane and
growth cones. Although the observed trafﬁcking of the EP4 receptor to
the plasma membrane induced by PGE2 and the EP4-speciﬁc agonist is
compelling, the potential contribution of remaining EP receptors needs
to be considered as well.In summary, these results conﬁrm that the EP4 externalization
from the Golgi apparatus to the plasma membrane in NE-4C stem
cells is PGE2-induced. Furthermore, this study provides the ﬁrst
evidence that PGE2 can also enhance the growth cone localization
of the EP4 receptor in differentiating NE-4C neuronal cells. Our
results show that the important role of the PGE2/EP4 pathway in
the developing nervous system may depend on the subcellular
localization of the EP4 receptor.Acknowledgements
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